Regulated-market entry often stalls because the proposition, evidence and buying route are out of sequence. Before increasing activity, establish who needs to act, what they need to see and which decision comes first.
Product suitability, implementation effort, funding and procurement can all matter. More introductions or more marketing cannot resolve every one of those constraints.
Three questions before more activity
Who needs to make the next decision? The user, sponsor, budget holder and procurement team may have different responsibilities. Identify the person or group whose action would allow the work to progress.
What evidence does that decision require? A useful conversation about an operational problem is different from a decision to fund or adopt a product. Match the evidence to the actual decision rather than presenting the same sales material to everyone.
What has to happen first? A credible sequence may depend on a sponsor, a defined use case, an evaluation or a funding route. Establish those dependencies before committing more sales effort.
An illustrative sequence
Consider a health technology business exploring adoption in a new care setting. This is a discussion example, not a client case or a universal procurement pathway.
The first step might be to establish whether the intended users recognise the problem and whether the proposed workflow is realistic. A subsequent discussion might examine evidence requirements and operational ownership. Only then might it be useful to clarify funding and the procurement route with the relevant decision-makers.
The order will vary by product and organisation. The purpose of mapping it is to make those differences visible. A meeting is useful when it resolves an uncertainty or enables a decision, not simply because it took place.
Prepare the next conversation
Approaching a stakeholder before the proposition is ready can make the next conversation harder. Prepare the evidence for the decision that person actually needs to make. Be clear about what is known, what is being tested and what you are asking them to do.
Record what the conversation changes. A positive response is encouraging, but it is not the same as a buying commitment.
Connect market access to the business plan
The wider leadership questions still matter: whether this is the right segment, whether the business can support adoption and whether the likely opportunity justifies the investment.
Specialist market-access advisers, agencies and fractional leaders can all contribute. Retained board advisory can help connect their work to the wider commercial choices where a continuing relationship is useful.
Choose support according to the constraint. If the immediate need is a narrow evidence or procurement task, specialist depth may be the priority. If the problem spans market choice, investment and organisational capacity, bring those decisions into the same discussion.
